Dallas, March 03, 2022 (GLOBE NEWSWIRE) -- As per the report published by The Brainy Insights, the global pharmacogenomics (PGx) market is expected to grow from USD 6.73 billion in 2020 to USD 11.63 ...
The PGX ETF provides exposure to an index of fixed-rate preferred shares. PGX pays a generous 5.8% trailing distribution yield. Historically, PGX total returns are primarily driven by interest rates ...
PGX invests primarily in fixed-rate preferred securities and bonds, offering diversified exposure with an average credit rating of BBB and a 0.5% management fee. A significant portion of the portfolio ...
In trading on Thursday, shares of the Invesco Preferred ETF (Symbol: PGX) entered into oversold territory, changing hands as low as $11.19 per share. We define oversold territory using the Relative ...
Prostate cancer (PC) is a significant health concern, being the second leading cause of death among American men. The standard treatment for advanced PC often involves androgen deprivation therapy ...
Income-minded investors who are looking for ways to enhance their yield generation in a lower-for-longer rate environment can consider preferreds-related exchange traded funds for more attractive ...
KENILWORTH, N.J.--(BUSINESS WIRE)--With adverse drug events (ADEs) triggering an estimated 700,000 ED visits and 120,000 hospitalizations, RDx BioScience (RDx) points ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results